A Critical Role of Neutrophil-Driven Amplification of Chronic Microinflammation in the Biocompatibility of Hemodialysis
Open Access
- 4 July 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6472
Abstract
This review highlights recent insights into the pathophysiology and therapeutic strategies for improving biocompatibility in hemodialysis. Hemodialysis activates the innate immune system, particularly the complement cascade and neutrophils, leading to acute microinflammation. Interleukin-8 (IL-8), which increases during dialysis, promotes neutrophil chemotaxis and neutrophil extracellular trap (NET) formation, triggering myeloperoxidase (MPO) release and oxidative stress. Neutrophil accumulation in atherosclerotic plaques exacerbates vascular inflammation through IL-6 upregulation. Elevated levels of IL-8, MPO, and NET-related biomarkers are associated with increased all-cause and cardiovascular mortality in dialysis patients. Strategies to mitigate these effects include the use of advanced membrane materials (e.g., AN69, vitamin E-coated, polymethyl methacrylate), novel dialysis modalities (e.g., high-volume online hemodiafiltration, cool dialysate, hydrogen-enriched dialysate), and citrate-based anticoagulation. These approaches aim to suppress complement activation, reduce oxidative stress, and limit neutrophil-induced damage. Enhancing biocompatibility is crucial for reducing cardiovascular complications and improving outcomes in dialysis patients. Suppressing the innate immune response during dialysis may become a future cornerstone in extracorporeal blood purification therapy.Keywords
Funding Information
- Tohoku University Hospital, Division of Blood purification
This publication has 109 references indexed in Scilit:
- IL-6 and Cardiovascular Risk: A Narrative ReviewCurrent Atherosclerosis Reports, 2024
- Interleukin‐6 levels can be used to estimate cardiovascular and all‐cause mortality risk in dialysis patients: A meta‐analysis and a systematic reviewImmunity, Inflammation and Disease, 2023
- The innate immune system in human kidney inflammagingJournal Of Nephrology, 2021
- On-line hemodiafiltration modulates atherosclerosis signaling in peripheral lymphomonocytes of hemodialysis patientsJournal Of Nephrology, 2021
- Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney InjuryJAMA, 2020
- Prognostic role of circulating neutrophil extracellular traps levels for long-term mortality in new end-stage renal disease patientsClinical Immunology, 2020
- Damage-associated molecular patterns derived from mitochondria may contribute to the hemodialysis-associated inflammationInternational Urology and Nephrology, 2013
- Development of vitamin E-modified polysulfone membrane dialyzersJournal of Artificial Organs, 2006
- Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytesBiomaterials, 2004
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001